Minnesota SF1947 mandates coverage of nonopioid drugs for pain management, ensuring no disadvantage compared to opioids.

Minnesota SF1947 amends state statutes to require the coverage of nonopioid drugs for pain treatment or management. The bill mandates that the commissioner of health must not disadvantage or discourage the coverage of nonopioid drugs approved by the U.S. Food and Drug Administration. This requirement applies immediately upon FDA approval, regardless of prior review by the commissioner or the Formulary Committee. The commissioner must also consider the impact on public health policies and health disparities before modifying the preferred drug list.

Minnesota SF1947 mandates coverage of nonopioid drugs for pain management, ensuring no disadvantage compared to opioids.

Minnesota SF1947 amends state statutes to require the coverage of nonopioid drugs for pain treatment or management. The bill mandates that the commissioner of health must not disadvantage or discourage the coverage of nonopioid drugs approved by the U.S. Food and Drug Administration. This requirement applies immediately upon FDA approval, regardless of prior review by the commissioner or the Formulary Committee. The commissioner must also consider the impact on public health policies and health disparities before modifying the preferred drug list.